Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells

International Journal of Oncology

Volumn 43, Issue 3, 2013, Pages 936-946

  Yang, Yu Xiu ^a   Li, Xiu Ling ^a   Wang, Lei ^b   Han, Shuang Yin ^a   Zhang, Yan Rui ^a   Pratheeshkumar, Poyil ^b   Wang, Xin ^b   Lu, Jian ^b   Yin, Yuan Qin ^b   Sun, Li Juan ^b   Budhraja, Amit ^b   Hitron, Andrew J ^b   Ding, Song Ze ^a,b  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Bcl 2; Bcl xL; BEAS 2B cell; Carcinogenesis; Lung cancer; Nickel; Oxidative stress; Tumor

Indexed keywords

CATALASE; NICKEL CHLORIDE; PROTEIN BCL 2; PROTEIN BCL XL; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL DEATH; CELL ONCOGENE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

APOPTOSIS; BCL-X PROTEIN; CATALASE; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NICKEL; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING;

EID: 84880589209     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2004     Document Type: Article

References (34)

1. Costa M: Molecular mechanisms of nickel carcinogenesis. Annu Rev Pharmacol Toxicol 31: 321-337, 1991.
2. Doll R, Morgan LG and Speizer FE: Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer 24: 623-632, 1970.
3. Costa M, Davidson TL, Chen H, et al: Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592: 79-88, 2005.
4. Lu H, Shi X, Costa M and Huang C: Carcinogenic effect of nickel compounds. Mol Cell Biochem 279: 45-67, 2005.
5. Salnikow K and Zhitkovich A: Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21: 28-44, 2008.
6. Salnikow K and Costa M: Epigenetic mechanisms of nickel carcinogenesis. J Environ Pathol Toxicol Oncol 19: 307-318, 2000.
7. Davidson T, Chen H, Garrick MD, D'Angelo G and Costa M: Soluble nickel interferes with cellular iron homeostasis. Mol Cell Biochem 279: 157-162, 2005.
8. Pan J, Chang Q, Wang X, et al: Reactive oxygen species-activated Akt/ASK1/p38 signaling pathway in nickel compound-induced apoptosis in BEAS 2B cells. Chem Res Toxicol 23: 568-577, 2010.
9. Pan JJ, Chang QS, Wang X, et al: Activation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells. Int J Oncol 39: 1285-1294, 2011.
10. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002.
11. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
12. Pugazhenthi S, Nesterova A, Sable C, et al: Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766, 2000.
13. Ding SZ, Yang YX, Li XL, et al: Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. Toxicol Appl Pharmacol 269: 61-71, 2013.
14. Zhou BP, Hu MC, Miller SA, et al: HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem 275: 8027-8031, 2000.
15. Ding SZ, Fischer W, Kaparakis-Liaskos M, et al: Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS One 5: e9875, 2010.
16. Cossarizza A, Baccarani-Contri M, Kalashnikova G and Franceschi C: A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197: 40-45, 1993.
17. Cheng EH, Wei MC, Weiler S, et al: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711, 2001.
18. Chang Q, Pan J, Wang X, Zhang Z, Chen F and Shi X: Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells. Cancer Res 70: 5127-5135, 2010.
19. Dunnick JK, Elwell MR, Radovsky AE, et al: Comparative carcinogenic effects of nickel subsulfide, nickel oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res 55: 5251-5256, 1995.
20. Oller AR, Costa M and Oberdorster G: Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol 143: 152-166, 1997.
21. Zhao J, Shi X, Castranova V and Ding M: Occupational toxicology of nickel and nickel compounds. J Environ Pathol Toxicol Oncol 28: 177-208, 2009.
22. Kim YJ, Ahn JY, Liang P, Ip C, Zhang Y and Park YM: Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-554, 2007.
23. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
24. Catz SD and Johnson JL: Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 20: 7342-7351, 2001.
25. Bigelow RL, Chari NS, Unden AB, et al: Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem 279: 1197-1205, 2004.
26. Ding J, Zhang X, Li J, et al: Nickel compounds render anti-apoptotic effect to human bronchial epithelial BEAS-2B cells by induction of cyclooxygenase-2 through an IKKbeta/p65-dependent and IKKalpha- and p50-independent pathway. J Biol Chem 281: 39022-39032, 2006.
27. Lawlor MA and Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910, 2001.
28. Morley S, Wagner J, Kauppinen K, Sherman M and Manor D: Requirement for Akt-mediated survival in cell transformation by the dbl oncogene. Cell Signal 19: 211-218, 2007.
29. Bellacosa A, Kumar CC, Di Cristofano A and Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94: 29-86, 2005.
30. Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274, 2007.
31. Li Q, Suen TC, Sun H, Arita A and Costa M: Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathway. Toxicol Appl Pharmacol 235: 191-198, 2009.
32. Ding J, He G, Gong W, et al: Effects of nickel on cyclin expression, cell cycle progression and cell proliferation in human pulmonary cells. Cancer Epidemiol Biomarkers Prev 18: 1720-1729, 2009.
33. Kim K, Lee SH, Seo YR, Perkins SN and Kasprzak KS: Nickel(II)-induced apoptosis in murine T cell hybridoma cells is associated with increased fas ligand expression. Toxicol Appl Pharmacol 185: 41-47, 2002.
34. Zhao J, Bowman L, Zhang X, et al: Metallic nickel nano- and fine particles induce JB6 cell apoptosis through a caspase-8/AIF mediated cytochrome c-independent pathway. J Nanobiotechnol 7: 2, 2009.